182 related articles for article (PubMed ID: 20217603)
1. LHRH-targeted nanoparticles for cancer therapeutics.
Minko T; Patil ML; Zhang M; Khandare JJ; Saad M; Chandna P; Taratula O
Methods Mol Biol; 2010; 624():281-94. PubMed ID: 20217603
[TBL] [Abstract][Full Text] [Related]
2. Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery.
Patil ML; Zhang M; Betigeri S; Taratula O; He H; Minko T
Bioconjug Chem; 2008 Jul; 19(7):1396-403. PubMed ID: 18576676
[TBL] [Abstract][Full Text] [Related]
3. Colloidal gold: a novel nanoparticle for targeted cancer therapeutics.
Powell AC; Paciotti GF; Libutti SK
Methods Mol Biol; 2010; 624():375-84. PubMed ID: 20217609
[TBL] [Abstract][Full Text] [Related]
4. Polymeric nanoparticles for drug delivery.
Chan JM; Valencia PM; Zhang L; Langer R; Farokhzad OC
Methods Mol Biol; 2010; 624():163-75. PubMed ID: 20217595
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biodistribution, and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99m labeled PEGylated dendrimer poly(amidoamine) (PAMAM)-folic acid conjugates.
Zhang Y; Sun Y; Xu X; Zhang X; Zhu H; Huang L; Qi Y; Shen YM
J Med Chem; 2010 Apr; 53(8):3262-72. PubMed ID: 20350006
[TBL] [Abstract][Full Text] [Related]
6. HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting.
Zhang Z; Chen J; Ding L; Jin H; Lovell JF; Corbin IR; Cao W; Lo PC; Yang M; Tsao MS; Luo Q; Zheng G
Small; 2010 Feb; 6(3):430-7. PubMed ID: 19957284
[TBL] [Abstract][Full Text] [Related]
7. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
Majoros IJ; Myc A; Thomas T; Mehta CB; Baker JR
Biomacromolecules; 2006 Feb; 7(2):572-9. PubMed ID: 16471932
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery.
Najlah M; D'Emanuele A
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):756-67. PubMed ID: 17987527
[TBL] [Abstract][Full Text] [Related]
9. Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo.
Zhang XY; Chen J; Zheng YF; Gao XL; Kang Y; Liu JC; Cheng MJ; Sun H; Xu CJ
Cancer Res; 2009 Aug; 69(16):6506-14. PubMed ID: 19638590
[TBL] [Abstract][Full Text] [Related]
10. Electrophoretic mobility and molecular distribution studies of poly(amidoamine) dendrimers of defined charges.
Shi X; Bányai I; Rodriguez K; Islam MT; Lesniak W; Balogh P; Balogh LP; Baker JR
Electrophoresis; 2006 May; 27(9):1758-67. PubMed ID: 16586414
[TBL] [Abstract][Full Text] [Related]
11. Use of nanoparticles for targeted, noninvasive thermal destruction of malignant cells.
Cherukuri P; Curley SA
Methods Mol Biol; 2010; 624():359-73. PubMed ID: 20217608
[TBL] [Abstract][Full Text] [Related]
12. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
Tomalia DA; Reyna LA; Svenson S
Biochem Soc Trans; 2007 Feb; 35(Pt 1):61-7. PubMed ID: 17233602
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
[TBL] [Abstract][Full Text] [Related]
14. Targeting cancer cells with biotin-dendrimer conjugates.
Yang W; Cheng Y; Xu T; Wang X; Wen LP
Eur J Med Chem; 2009 Feb; 44(2):862-8. PubMed ID: 18550227
[TBL] [Abstract][Full Text] [Related]
15. Targeting of nanoparticles: folate receptor.
Kularatne SA; Low PS
Methods Mol Biol; 2010; 624():249-65. PubMed ID: 20217601
[TBL] [Abstract][Full Text] [Related]
16. Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting.
Patil ML; Zhang M; Taratula O; Garbuzenko OB; He H; Minko T
Biomacromolecules; 2009 Feb; 10(2):258-66. PubMed ID: 19159248
[TBL] [Abstract][Full Text] [Related]
17. Coordination and reduction processes in the synthesis of dendrimer-encapsulated Pt nanoparticles.
Yamamoto D; Watanabe S; Miyahara MT
Langmuir; 2010 Feb; 26(4):2339-45. PubMed ID: 20141201
[TBL] [Abstract][Full Text] [Related]
18. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer.
Shenoy DB; Amiji MM
Int J Pharm; 2005 Apr; 293(1-2):261-70. PubMed ID: 15778064
[TBL] [Abstract][Full Text] [Related]
19. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability.
Kolhatkar RB; Kitchens KM; Swaan PW; Ghandehari H
Bioconjug Chem; 2007; 18(6):2054-60. PubMed ID: 17960872
[TBL] [Abstract][Full Text] [Related]
20. Transepithelial and endothelial transport of poly (amidoamine) dendrimers.
Kitchens KM; El-Sayed ME; Ghandehari H
Adv Drug Deliv Rev; 2005 Dec; 57(15):2163-76. PubMed ID: 16289433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]